HFS
AKBA icon

Hughes Financial Services’s Akebia Therapeutics AKBA Stock Holding History

Hughes Financial Services’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15
Closed -$21 – 1844
2026
Q1 		$21 Buy
+15
New +$21 ﹤0.01% 1605

Other funds holding AKBA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
IWN
Independent Wealth Network Urbandale, Iowa $393M AUM 30.08% 1-Year Est. Return
LPT
Legacy Private Trust Neenah, Wisconsin $1.81B AUM 19.87% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
EWS
Eagle Wealth Strategies West Deptford, New Jersey $262M AUM 31.52% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Hughes Financial Services's AKBA Position: Q2 2026 in Review

Hughes Financial Services sold out of Akebia Therapeutics (AKBA) in Q2 2026, closing a stake of 15 shares — an estimated $21 sold.

Hughes Financial Services first reported a position in AKBA in Q1 2026 and held it in 1 quarter. The position peaked at $21 in Q1 2026. 15 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Hughes Financial Services reported no remaining Akebia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Hughes Financial Services sold 15 Akebia Therapeutics shares in Q2 2026, an estimated $21.
  • Hughes Financial Services first reported a position in Akebia Therapeutics in Q1 2026 and held it in 1 quarter.
  • Hughes Financial Services's Akebia Therapeutics position peaked at $21 in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.